Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene editing
gene editing
First look at Verve study data offer base editing ‘proof of principle’
BioPharma Dive
Sun, 11/12/23 - 09:27 pm
Verve Therapeutics
heart disease
gene editing
As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations
Fierce Pharma
Tue, 11/7/23 - 11:47 am
Vertex Pharmaceuticals
CRISPR
gene editing
FDA
exa-cel
Lilly buys Beam’s option on Verve drug programs
Pharmaforum
Tue, 10/31/23 - 10:06 am
Eli Lilly
gene editing
Beam Therapeutics
Verve Therapeutics
Verve gets FDA green light to run base editing study in US
BioPharma Dive
Mon, 10/23/23 - 05:01 pm
Verve Therapeutics
FDA
gene editing
heart disease
clinical trials
Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
Investors Business Daily
Thu, 10/19/23 - 10:12 am
Intellia
CRISPR
gene editing
transthyretin amyloidosis with cardiomyopathy
A decade later, biotech’s CRISPR revolution is still going strong
BioPharma Dive
Thu, 10/12/23 - 05:14 pm
CRISPR
gene editing
biotech
Why Shares of Tango Therapeutics Climbed This Week
Motley Fool
Thu, 09/14/23 - 10:56 pm
Tango Therapeutics
CRISPR
gene editing
clinical trials
Amber Bio Raises $26 Million Seed Financing to Advance New RNA-Based Gene Editing Platform
Yahoo/Businesswire
Thu, 08/3/23 - 10:15 am
Amber Bio
funding
gene editing
RNA
Gene editing biotech Homology hits reset and seeks a sale
BioPharma Dive
Fri, 07/28/23 - 10:35 am
Homology
PKU
gene editing
M&A
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
Forbes
Wed, 07/26/23 - 06:22 pm
Scribe Therapeutics
CRISPR
gene editing
Benjamin Oakes
Sanofi expands research deal with gene editing startup Scribe
BioPharma Dive
Tue, 07/18/23 - 10:28 am
Sanofi
gene editing
Scribe Therapeutics
Pfizer pours $25M investment into Caribou's cell therapies
Fierce Biotech
Thu, 07/6/23 - 10:19 am
Pfizer
Caribou Biosciences
gene editing
CAR-T
Multiple Myeloma
Verve partners with Lilly on gene editing therapy for heart disease
BioPharma Dive
Thu, 06/15/23 - 10:02 am
Eli Lilly
Verve Therapeutics
heart disease
gene editing
Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
BioSpace
Mon, 06/12/23 - 09:58 am
gene editing
Editas Medicine
Vertex Pharmaceuticals
CRISPR Therapeutics
EDIT-301
sickle cell disease
beta thalassemia
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Fri, 06/9/23 - 10:07 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
FDA
sickle cell disease
beta thalassemia
Bayer licenses lipid nanoparticle tech for gene therapy
BioProcess International
Wed, 06/7/23 - 10:17 am
Bayer
Acuitas Therapeutics
gene editing
Novo makes a gene editing move
EP Vantage
Wed, 05/24/23 - 10:20 am
Novo Nordisk
gene editing
Life Edit Therapeutics
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
BioSpace
Thu, 05/18/23 - 11:21 am
AstraZeneca
Revvity
gene editing
cell therapy
Gene Editing Therapeutics Could Hit the Market in 2023
BioSpace
Mon, 04/10/23 - 11:32 am
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia Therapeutics
Editas Medicine
Beam Therapeutics
Intellia Seeks to Broaden Gene Editing’s Potential with Full-Spectrum Approach
BioSpace
Mon, 04/3/23 - 09:55 am
gene editing
Intellia Therapeutics
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »